Stichting Hemato-oncologie Voor Volwassenen Nederland

This study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent relapse in people with high-risk diffuse large B-cell lymphoma. About 109 adults who achieved complete remission after initial treatment received atezolizumab as a con…

This study tests a drug called zanubrutinib in 25 people with cold agglutinin disease, a rare condition where the immune system destroys red blood cells, especially in cold weather. The drug targets the cells that make the harmful antibodies. The goal is to see if it can control …

This study tests a drug called tislelizumab combined with chemotherapy for people whose Hodgkin lymphoma has returned or not responded to initial treatment. The goal is to see if this approach works as well as the standard intensive chemo and stem cell transplant. About 75 adults…